KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,098 | -25.1% | 47,088 | 0.0% | 0.00% | – |
| Q2 2023 | $84,288 | -24.7% | 47,088 | +63.7% | 0.00% | – |
| Q1 2023 | $111,876 | +14.4% | 28,760 | 0.0% | 0.00% | – |
| Q4 2022 | $97,784 | -38.3% | 28,760 | -0.9% | 0.00% | – |
| Q3 2022 | $158,449 | +17.8% | 29,020 | -2.7% | 0.00% | – |
| Q2 2022 | $134,520 | -38.1% | 29,827 | +1.1% | 0.00% | – |
| Q1 2022 | $217,400 | -11.6% | 29,498 | -23.0% | 0.00% | – |
| Q4 2021 | $246,000 | +7.9% | 38,301 | -2.2% | 0.00% | – |
| Q3 2021 | $228,000 | -45.1% | 39,173 | -2.5% | 0.00% | – |
| Q2 2021 | $415,000 | -3.5% | 40,167 | -1.6% | 0.00% | – |
| Q1 2021 | $430,000 | -32.0% | 40,832 | -0.1% | 0.00% | -100.0% |
| Q4 2020 | $632,000 | +9.3% | 40,857 | +3.1% | 0.00% | 0.0% |
| Q3 2020 | $578,000 | -20.4% | 39,618 | -1.8% | 0.00% | 0.0% |
| Q2 2020 | $726,000 | +3.4% | 40,344 | +10.4% | 0.00% | 0.0% |
| Q1 2020 | $702,000 | +7.8% | 36,547 | +7.6% | 0.00% | 0.0% |
| Q4 2019 | $651,000 | +84.9% | 33,981 | -5.1% | 0.00% | – |
| Q3 2019 | $352,000 | +63.7% | 35,810 | -0.4% | 0.00% | – |
| Q2 2019 | $215,000 | +13.2% | 35,956 | +10.7% | 0.00% | – |
| Q1 2019 | $190,000 | -33.1% | 32,466 | +7.2% | 0.00% | – |
| Q4 2018 | $284,000 | -46.3% | 30,297 | -2.4% | 0.00% | -100.0% |
| Q3 2018 | $529,000 | -11.5% | 31,045 | -11.7% | 0.00% | 0.0% |
| Q2 2018 | $598,000 | +71.8% | 35,164 | +35.6% | 0.00% | – |
| Q1 2018 | $348,000 | +35.9% | 25,929 | -3.0% | 0.00% | – |
| Q4 2017 | $256,000 | -10.8% | 26,729 | +2.5% | 0.00% | – |
| Q3 2017 | $287,000 | +18.1% | 26,084 | -3.1% | 0.00% | – |
| Q2 2017 | $243,000 | -11.3% | 26,907 | +26.2% | 0.00% | – |
| Q1 2017 | $274,000 | +58.4% | 21,321 | +15.5% | 0.00% | – |
| Q4 2016 | $173,000 | +6.8% | 18,465 | +10.5% | 0.00% | – |
| Q3 2016 | $162,000 | +40.9% | 16,703 | -2.1% | 0.00% | – |
| Q2 2016 | $115,000 | -13.5% | 17,059 | +11.2% | 0.00% | – |
| Q1 2016 | $133,000 | -32.8% | 15,337 | +2.5% | 0.00% | – |
| Q4 2015 | $198,000 | +29.4% | 14,959 | +2.9% | 0.00% | – |
| Q3 2015 | $153,000 | -60.5% | 14,544 | +2.2% | 0.00% | – |
| Q2 2015 | $387,000 | +32.1% | 14,229 | +48.4% | 0.00% | – |
| Q1 2015 | $293,000 | -5.2% | 9,590 | +16.0% | 0.00% | – |
| Q4 2014 | $309,000 | +4.4% | 8,268 | -2.4% | 0.00% | – |
| Q3 2014 | $296,000 | -16.6% | 8,472 | +10.9% | 0.00% | -100.0% |
| Q2 2014 | $355,000 | +104.0% | 7,638 | +36.0% | 0.00% | – |
| Q1 2014 | $174,000 | – | 5,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |